Table 2.

Detailed clinical and laboratory data of COVID-19 patients.

ID	Age (Years)	Gender (M/F)	Smoking	Comorbidities	Enoxaparin (Anticoagulant Therapy)	Antibiotic Therapy	Antiviral Therapy	Tolicizumab	Tracheal Intubation	Length of Invasive Ventilation (Days)	ICU	ICU Stay (Days)	Hospitalization (Days)	Lymphocyte Count (109/L)	D-Dimer (ng/mL)	Fibrinogen (mg/dL)	IL-6 (ng/L)	Ferritin (ng/mL)	LDH (U/L)
1	82	M	No	Yes	Yes	Yes	Yes	N	N	-	Yes	1	2	0.51	311	na	na	na	427
2	69	F	No	Yes	Yes	Yes	Yes	No	Yes	5	Yes	5	4	1.14	55.744	0.8	na	na	406
3	76	M	No	Yes	No	Yes	Yes	No	Yes	5	Yes	5	4	1.3	315	6.8	66.8	485	369
4	71	M	No	Yes	Yes	Yes	No	No	Yes	1	Yes	1	5	9.88	684	3.3	na	na	na
5	87	F	Former	Yes	Yes	Yes	No	No	No	-	No	-	4	na	na	na	na	na	660
6	79	M	Yes	Yes	Yes	Yes	No	No	Yes	6	Yes	7	7	0.7	1276	7.6	210	4253	446
7	76	M	No	Yes	Yes	Yes	Yes	No	Yes	19	Yes	19	26	1.32	268	4.6	na	na	na
8	96	M	No	Yes	Yes	Yes	No	No	No	-	No	-	4	0.92	1189	7.6	299	2416	217
9	86	M	No	Yes	Yes	Yes	No	No	No	-	No	-	6	0.28	5329	na	na	915	434
10	90	F	No	Yes	Yes	Yes	No	No	No	-	No	-	4	1.09	4029	na	na	na	na
11	75	M	No	No	Yes	Yes	Yes	No	Yes	-	Yes	20	21	0.93	910	7.5	878	3089	104
12	88	F	No	Yes	Yes	Yes	No	No	No	-	No	-	6	0.95	222	na	na	524	219
13	74	F	Former	Yes	Yes	Yes	Yes	No	Yes	8	Yes	11	13	0.57	969	8.19	18	363	247
14	87	F	No	Yes	No	Yes	No	No	No	-	No	-	0	0.43	na	na	na	na	766
15	92	F	No	Yes	Yes	Yes	No	No	No	-	No	-	5	na	na	na	na	na	556
16	83	M	Former	Yes	Yes	Yes	Yes	No	No	-	No	-	8	0.35	na	na	na	na	na
17	97	F	No	Yes	Yes	Yes	No	No	No	-	No	-	9	0.52	507	4.1	na	669	286